1. Introduction {#s0005}
===============

During the past 50 years, Western populations have experienced changes in both type and amount of dietary fat [@bb0005]. For example, the introduction of margarine increased the dietary intake of the 18:2n-6 and so increased the dietary n-6:n-3 polyunsaturated fatty acid (PUFA) ratio and also increased consumption of *trans* fatty acids [@bb0005]. Furthermore, populations in developing countries migrating from rural to urban areas experience a persistent dietary change from a relatively low fat (LF) diet with a high monounsaturated fatty acid and PUFA content to a diet with a Western fat content and composition [@bb0010]. Such geographical and dietary transition is associated with increased prevalence of the metabolic syndrome and cardiovascular disease [@bb0015]. One explanation for these health effects is that environmental exposures during early life, including nutrition, can induce changes in the phenotype of the offspring that have implications for future risk of disease [@bb0020]. However, the mechanism by which maternal dietary fat intake induces long-term changes in the phenotype of the offspring has not been explored in detail.

In rodents, feeding a high-saturated fat diet during pregnancy and/or pregnancy and lactation induced in the offspring vascular dysfunction [@bb0025; @bb0030] and impaired control of lipid and glucose metabolism [@bb0035; @bb0040; @bb0045; @bb0050; @bb0055; @bb0060; @bb0065; @bb0070]. Furthermore, the offspring of mice fed a diet enriched in *trans* fatty acids during pregnancy and lactation showed growth retardation and impaired glucose homeostasis [@bb0075].

There is some evidence that changes in the regulation of membrane fatty acid composition in the offspring that persist beyond the period of exposure to the altered diet may be involved in phenotypes induced by fat exposures during development. Feeding rats diets containing 21% (w/w) total fat enriched in either saturated, n-6 PUFA, *trans* fatty acids or fish oil (FO) during pregnancy and lactation induced lower proportions of 20:4n-6 and 22:6n-3 in the aorta of adult offspring [@bb0080]. Since the diet fed after weaning contained only the precursors 18:2n-6 and 18:3n-3, these findings suggest that a maternal high-saturated fat diet reduced capacity for 20:4n-6 and 22:6n-3 synthesis [@bb0080]. Furthermore, the type of fat fed to pregnant and lactating mice influenced the effect of the fat fed after weaning on the fatty acid composition of liver and heart in the offspring [@bb0080]. Feeding adult rats a high fat (HF) diet reduced the messenger RNA (mRNA) expression of *Fads2* that encodes Δ6 desaturase the rate-limiting enzyme in 20:4n-6 and 22:6n-3 synthesis in liver [@bb0085]. Thus, altered transcriptional regulation of *Fads2* and/or *Fads1*, which encodes Δ5 desaturase, represents one potential mechanism by which maternal fat intake may induce persistent changes in the PUFA content of cell membranes in the offspring.

A number of studies have shown that long-term phenotypic changes induced by unbalanced prenatal nutrition involve altered epigenetic regulation of specific genes [@bb0090]. However, there is limited information about the effect of maternal dietary fat on epigenetic processes in the offspring. *Fads2* transcription has been shown to be regulated by the methylation status of its promoter in rodents [@bb0080; @bb0095]. Feeding HF diets to pregnant and lactating rats induced increased methylation of specific CpG dinucleotides in the *Fads2* promoter and lower mRNA expression in adult offspring aorta [@bb0080]. One CpG at −394 bases from the transcription start site was hypermethylated in the offspring of dams fed an HF diet and was shown to be involved directly in the regulation of *Fads2* expression. Feeding an HF diet of undisclosed composition to pregnant and lactating mice induced global hypomethylation and lower average methylation of specific genes in the brain of the offspring [@bb0100]. Supplementation of U937 leukaemia cells with 20:5n-3 induced demethylation of specific CpG dinucleotides in the CCAAT/enhancer-binding protein-δ promoter [@bb0105]. Thus, we hypothesised that variations in the type and amount of fat consumed by pregnant and lactating rats induce changes in liver and plasma PUFA status in their offspring by a mechanism that involves altered epigenetic regulation of hepatic Fads genes.

To test this idea, rats were fed diets containing graded amounts of fat enriched in either saturated fatty acids (butter) or in 20:5n-3 and 22:6n-3 FO before and during pregnancy and during lactation. Male and female offspring were fed an LF diet in which the only PUFA were 18:2n-6 and 18:3n-3 until postnatal day 77. The effects of the maternal diets on PUFA status were determined by measuring the fatty acid composition of offspring liver and plasma phospholipids. The effects of maternal dietary fat on the epigenetic regulation of PUFA biosynthesis in the offspring were assessed by hepatic *Fads1* and *Fads2* mRNA expression and the methylation of specific CpG dinucleotides in the *Fads2* promoter. We also compared the effect of differences in maternal fat intake on the epigenetic regulation of hepatic *Fads2* in the offspring with the effect of feeding adult non-pregnant female rats different fats.

2. Materials and methods {#s0010}
========================

2.1. Animal procedures {#s0015}
----------------------

All animal procedures were in accordance with the British Home Office Animals (Scientific Procedures) Act 1986. Virgin female Wistar rats weighing 200--250 g were fed diets based on the AIN-93G formulation [@bb0110] containing either 3.5% (LF), 7% \[adequate fat (AF)\] or 21% (HF) (w/w) total fat derived from either butter, predominately saturated and monounsaturated fatty acids, or FO, predominately n-3 PUFA ([Supplemental Table 1](#ec0005){ref-type="supplementary-material"}), from 14 days before conception and throughout pregnancy and lactation (*n*=6 per diet). The AF diets provided an adequate amount of fat to support pregnancy and lactation in rats [@bb0110] and so represent the reference group. All diets contained the same amount of vitamin E to provide sufficient antioxidant capacity at the highest level of FO intake. Litters were culled to 8 pups (equal numbers of males and females) within 24 h of spontaneous birth. Offspring (*n*=6 males or females, 1 male and 1 female in each litter per maternal diet) were weaned at 28 day onto AIN-93M diet containing 4% (w/w) soybean oil ([Supplemental Table 1](#ec0005){ref-type="supplementary-material"}) and maintained on this diet until postnatal day 77 when they were fasted for 12 h and then killed by CO~2~ asphyxiation. Dams were fasted for 12 h and then killed on postpartum day 28.

In order to compare the effects of differences in fat exposure during development with the effect on adult animals, virgin female rats (200--250 g) were either maintained on AIN-93M for 13 weeks (*n*=6) and then killed, fed AF FO for 9 weeks (the period equivalent to the dams that were fed this diet) and then killed (*n*=6) or transferred from AF FO to AIN-93M for 4 weeks and then killed (*n*=6). All females were fasted for 12 h before killing by CO~2~ asphyxiation.

Blood was collected by cardiac puncture into tubes containing lithium heparin and plasma separated from cells by centrifugation. Plasma was stored at −80°C. Livers were removed immediately into liquid nitrogen and stored at −80°C.

2.2. Measurement of fatty acid composition {#s0020}
------------------------------------------

Plasma and liver fatty acid compositions were measured as described [@bb0115]. Briefly, liver (approximately 100 mg) was powdered under liquid nitrogen and total lipids extracted with chloroform and methanol [@bb0120]. Plasma (0.8 ml) was extracted with chloroform and methanol [@bb0120]. Triacylglycerol (TAG), phosphatidylcholine (PC) and phosphatidylethanolamine (PE) were isolated by solid-phase extraction using 100 mg BondElut aminopropyl silica cartridges (Agilent, Stockport, Cheshire, UK) [@bb0115; @bb0125] and converted to fatty acid methyl esters (FAMEs) by incubation with methanol containing 2% (v/v) sulphuric acid [@bb0115]. The proportions of individual fatty acids were measured by gas chromatography using BPX70 fused silica capillary column (30 m × 0.25 mm × 0.25 μm) (SGE Europe Ltd., Milton Keynes, Buckinghamshire, UK) on an Agilent 6890 gas chromatograph equipped with flame ionisation detection [@bb0115]. FAMEs were identified by their retention times relative to standards and quantified using Chemstation software (Agilent).

2.3. Measurement of *Fads1* and *Fads2* mRNA expression {#s0025}
-------------------------------------------------------

Real-time reverse transcription (RT) polymerase chain reaction (PCR) was carried out essentially as described [@bb0130]. Total RNA was isolated from liver using Tri Reagent (Sigma, Poole, Dorset, UK). Complementary DNA was prepared and amplified using real-time RT PCR. The level of *Fads2* mRNA was measured by QuantiTect assay QT00186739 (Qiagen, Crawley, West Sussex, UK) and *Fads1* mRNA by QuantiTect assay QT00188664 (Qiagen). Samples were analysed in duplicate and expression of the individual transcripts was normalised to cyclophilin (QuantiTect assay QT00177394; Qiagen) [@bb0135], which did not differ in transcript level between groups of offspring [@bb0140]. Expression relative to cyclophilin was determined by the standard curve method [@bb0145].

2.4. Measurement of DNA methylation {#s0030}
-----------------------------------

The level of methylation of individual CpG dinucleotides in the *Fads2* promoter was measured in a region between 0 and 766 bases upstream from the transcription start site ([Supplemental Fig. 1](#ec0005){ref-type="supplementary-material"}) using sodium bisulphite pyrosequencing [@bb0080]. This region encompasses CpGs that have been shown previously to be involved in regulation of *Fads2* transcription [@bb0080]. Genomic DNA was prepared and bisulphite conversion was carried out using the EZ DNA methylation kit (ZymoResearch, Irvine, CA, USA). The pyrosequencing reaction was carried out using primers listed in [Supplemental Table 2](#ec0005){ref-type="supplementary-material"}. Modified DNA was amplified using KAPA2G Robust Hot Start Taq DNA polymerase (Labtech, Ringmer, East Sussex, UK). PCR products were immobilised on streptavidin--sepharose beads (GE Healthcare UK Ltd., Amersham, Buckinghamshire, UK), washed, denatured and released into annealing buffer containing the sequencing primers. Pyrosequencing was carried out using the SQA kit on a PSQ 96MA machine (Biotage, Uppsala, Sweden), and the percentage methylation was calculated using the Pyro Q CpG software (Biotage). Within assay, precision was between 0.8% and 1.8% and detection limits were 2--5% methylation.

2.5. Statistical analysis {#s0035}
-------------------------

After testing for normality, dietary groups were compared by analysis of variance (ANOVA) with sex and amount and type of maternal dietary fat as between-subject factors with Bonferroni\'s post hoc test (SPSS, Chicago, IL, USA). Data are presented as mean±S.D. Differences between means with a probability \<.05 were assumed to be statistically significant. The strength of linear associations between outcome measures was assessed by Pearson\'s correlation analysis. Comparison between groups of adult rats fed different amounts of fat was by 1-way ANOVA with Bonferroni\'s post hoc test. Six rats per group provided statistical power of 80% for detecting a 5% difference between groups for all outcome measures with a probability of 5%.

3. Results {#s0040}
==========

3.1. Maternal dietary fat intake altered liver PC and PE and plasma PC fatty acid composition in adult offspring {#s0045}
----------------------------------------------------------------------------------------------------------------

Maternal fasting plasma TAG showed the expected differences in fatty acid composition between groups indicating the effectiveness of the dietary regimen ([Supplemental Table 3](#ec0005){ref-type="supplementary-material"}). Specifically, the proportions of 20:5n-3 and 22:6n-3 were higher in dams fed the FO diet compared to those fed butter and the level of these fatty acids was significantly greater in dams fed the HF diets compared to those fed LF and AF diets. 18:2n-6 did not differ between dams fed different amounts of butter but decreased in a dose-related manner in dams fed different amounts of FO.

The principal effects of differences in maternal dietary fat intake were on the proportions of 20:4n-6 and 22:6n-3 in offspring liver PC and PE and plasma PC. The proportions of 20:4n-6 and 22:6n-3 were significantly lower in liver PC from the offspring of dams fed HF diets compared to those fed the LF and AF diets. There was a minor effect of the fatty acid composition of the maternal diet on the proportion of 20:4n-6, but not 22:6n-3 ([Table 1](#t0005){ref-type="table"}). The relationship of 20:4n-6 and 22:6n-3 in plasma PC from male and female offspring to the amount of fat in the maternal diet was similar to that in liver PC ([Table 1](#t0005){ref-type="table"}). The proportions of 20:4n-6 and 22:6n-3 in liver PE showed an inverse relationship with the amount of fat in the maternal diet. This was accompanied by interactive effects of offspring sex and the type of fat in the maternal diet with the amount of dietary fat ([Table 1](#t0005){ref-type="table"}).

There were relatively small differences between maternal dietary groups in the proportion of 20:5n-3 in offspring liver PC and in the proportion of 20:3n-6 in liver PE ([Supplemental Tables 4 and 5](#ec0005){ref-type="supplementary-material"}). 18:2n-6 was significantly higher in liver PC and PE of the offspring of dams fed the HF diet compared to those fed the LF or AF diet ([Supplemental Tables 4 and 5](#ec0005){ref-type="supplementary-material"}). There were no significant differences in the proportions of 18:2n-6 and low abundance n-3 and n-6 PUFA in plasma PC between maternal dietary groups ([Supplemental Table 6](#ec0005){ref-type="supplementary-material"}).

3.2. Maternal dietary fat intake altered the mRNA expression of *Fads2* in adult offspring liver {#s0050}
------------------------------------------------------------------------------------------------

There were no statistically significant differences between groups in *Fads1* mRNA expression in male or female offspring ([Fig. 1](#f0005){ref-type="fig"}A and B). There were significant effects of offspring sex \[*P*=.002 (F 10.6)\] and the amount of maternal dietary fat \[*P*\<.0001 (F 49.1)\] on *Fads2* mRNA expression in the liver of the offspring ([Fig. 1](#f0005){ref-type="fig"}C and D). *Fads2* expression was significantly lower in male than female offspring. Increasing the amount of fat in the maternal diet decreased *Fads2* mRNA expression in male and female offspring ([Fig. 1](#f0005){ref-type="fig"}C and D).

3.3. Maternal dietary fat intake altered the methylation of specific CpG dinucleotides in the *Fads2* promoter in adult offspring liver {#s0055}
---------------------------------------------------------------------------------------------------------------------------------------

The methylation status of the 10 CpG dinucleotides in the proximal promoter of *Fads2*, which has been shown to contain the regulatory elements important for expression [@bb0080] ([Supplemental Fig. 1](#ec0005){ref-type="supplementary-material"}), was measured in the liver of the offspring. CpGs at −722, −711, −678, −608, −585 and −65 bases from the transcription start site showed no significant difference in methylation between maternal dietary groups in male or female offspring ([Supplemental Table 7](#ec0005){ref-type="supplementary-material"}). However, there were significant effects on the methylation of CpGs at −623, −394, −84 and −76 bases from the transcription start site of the amount \[all *P*\<.0001 (F 13--97)\] and type \[all *P*\<.0001 (F 60--150)\] of maternal dietary fat and of sex \[CpG −623, *P*=.44 (F 4.2); CpG −394, *P*=.012 (F 6.8); CpGs −84 (F 20.1) and −76 (F 21.2), both *P*\<.0001\] ([Fig. 2](#f0010){ref-type="fig"}). There were significant interaction effects of the amount and type of maternal dietary fat and of sex on the methylation of CpG −623 \[*P*=.03 (F 6.7)\], CpG −394 \[*P*=.007 (F 5.4)\], CpG −84 \[*P*=.01 (F 7.7)\] and CpG −76 \[*P*=.08 (F 5.9)\]. Methylation of these four CpGs increased with the amount of fat in the maternal diet, although the level of methylation tended to be greater in offspring of dams fed FO than butter ([Fig. 2](#f0010){ref-type="fig"}).

Methylation of the *Fads1* promoter was below 5%, the detection limit of the pyrosequencing assays in all samples measured (data not shown).

3.4. Methylation of specific CpGs in the *Fads2* promoter was associated with the level of mRNA expression and 20:4n-6 and 22:6n-3 status {#s0060}
-----------------------------------------------------------------------------------------------------------------------------------------

*Fads2* mRNA expression correlated positively with the proportions of 20:4n-6 and 22:6n-3 in liver PC and PE and in plasma PC ([Table 2](#t0010){ref-type="table"}). Methylation of CpG −394 showed a strong negative correlation with *Fads2* mRNA expression in male and female offspring, while CpGs −623, −84 and −76 correlated weakly with *Fads2* mRNA expression ([Table 2](#t0010){ref-type="table"}). Methylation of CpG −394, but not CpGs −623, −84 and −76, correlated negatively with the proportions of 20:4n-6 and 22:6n-3 in liver PC and PE and in plasma PC in male and female offspring ([Table 2](#t0010){ref-type="table"}).

3.5. Feeding adult females a higher fat diet enriched in FO induced transient changes in the methylation of the *Fads2* promoter and its mRNA expression {#s0065}
--------------------------------------------------------------------------------------------------------------------------------------------------------

There were significant effects of diet on the proportions of 20:4n-6 and 22:6n-3 \[both *P*\<.0001 (F 47.4 and F 31.8, respectively)\] on *Fads2*, but not *Fads1*, mRNA expression and on the methylation of specific CpG dinucleotides \[−62, *P*=.006 (F 19.7); −694, *P*=.0014 (F 21.8); −84, *P*\<.0001 (F 33.1); −76, *P*=.0002 (F 24.4)\] in offspring liver ([Fig. 3](#f0015){ref-type="fig"}). Feeding the FO AF diet to non-pregnant females for 9 weeks decreased the proportion of 20:4n-6 and increased the proportion of 22:6n-3 in liver PC compared to females maintained on the AIN-94M diet ([Fig. 3](#f0015){ref-type="fig"}A and B). This was accompanied by a significant decrease in *Fads2* mRNA expression ([Fig. 3](#f0015){ref-type="fig"}D), but there was no difference in *Fads1* mRNA expression between groups ([Fig. 3](#f0015){ref-type="fig"}C). Methylation of CpGs −623, −394, −84 and −76 in the *Fads2* promoter was increased in females fed FO AF compared to those fed AIN-93M ([Fig. 3](#f0015){ref-type="fig"}E--H). However, transfer of females fed FO AF to AIN-93M for 4 weeks reversed the effects of the FO AF diet on the proportions of 20:4n-6 and 22:6n-3 in liver PC, *Fads2* mRNA expression and methylation of individual CpG dinucleotides in the *Fads2* promoter ([Fig. 3](#f0015){ref-type="fig"}).

4. Discussion {#s0070}
=============

The findings of this study support the hypothesis that maternal fat intake during pregnancy and lactation alters the proportions of PUFA, specifically 20:4n-6 and 22:6n-3, in the liver of the adult offspring and that this is associated with altered epigenetic regulation of *Fads2* transcription.

Increasing maternal fat intake during pregnancy and lactation has been shown to induce changes in the fatty acid composition of membrane phospholipids in the offspring that persist beyond the period when fatty acids are supplied from the mother may be expected to have been lost due to turnover [@bb0150; @bb0155]. The present findings show that the effects of the maternal diets on the fatty acid compositions of offspring liver and plasma phospholipids differed from those in maternal plasma TAG, a major substrate for supply of fatty acids to the offspring during pregnancy and lactation. This suggests that the maternal diets induced long-term changes in PUFA metabolism rather than persistence of fatty acids derived from the maternal diets in the offspring. Our findings are in general agreement with a previous report [@bb0155] but extend those observations by showing that the amount of fat consumed by dams exerted a substantially greater effect on the proportions of 20:4n-6 and 22:6n-3 in liver and plasma phospholipids than the fatty acid composition of the maternal diet. In the present study, all offspring were fed the same type of fat after weaning and so the findings are not directly comparable to those reported previously [@bb0150]. Since the only PUFA in the diet fed to the offspring after weaning were 18:3n-3 and 18:2n-6, one possible interpretation is that differences in 20:4n-6 and 22:6n-3 status reflect altered capacity for synthesis from these precursors. Thus, these findings suggest that differences in maternal dietary fat intake induce long-term changes in membrane PUFA content in the offspring by altering the metabolism of these fatty acids.

Our findings show for the first time that maternal fat intake was related inversely to *Fads2*, but not *Fads1*, mRNA expression in the offspring and, for example, that *Fads2* mRNA expression predicted in males 32% and 10% and in females 18% and 36%, of the variation in the proportions of 20:4n-6 and 22:6n-3, respectively, in liver PC. This suggests that differences in the regulation of *Fads2* transcription induced during development may be an important factor in future capacity to maintain liver and plasma 20:4n-6 and 22:6n-3 contents. However, while maternal dietary 7% fat appear to be a threshold for the effect of fat intake on PUFA status in the offspring, the effect on offspring *Fads2* expression was graded between the different amounts of fat in the maternal diet. One possible explanation for the difference in the effect of the maternal diet on fatty acid composition and *Fads2* expression is the influence of other factors regulating PUFA levels, such as rate of fatty acid turnover, which may mask the changes in gene expression at low to moderate maternal fat intakes.

We have shown previously that feeding rats an HF diet during pregnancy and lactation induced increased methylation of specific CpG dinucleotides in the *Fads2* promoter and decreased mRNA expression of this gene in offspring aorta and that this was associated with dysregulation of vascular tone [@bb0080]. Furthermore, methylation of CpG −394 was shown using a *Fads2* promoter-reporter gene construct to regulate *Fads2* transcription directly [@bb0080]. Our present findings show, for the first time, that both the type and the amount of maternal dietary fat induce persistent changes in the methylation of four CpG dinucleotides in the liver *Fads2* promoter in the liver of the adult offspring. Methylation levels of three CpGs, −394, −84 and −76, correlated negatively with the level of *Fads2* mRNA. CpG −394 methylation was also negatively associated with the proportion of 20:4n-6 and 22:6n-3 in liver and plasma phospholipids and variation in the methylation at this locus predicted up to 59% of the variation in 20:4n-6 in males and 71% in females and 53% of the variation in 22:6n-3 in males and 78% in females. Together, these findings support the suggestion that *Fads2* methylation is an important factor in regulating 20:4n-6 and 22:6n-3 levels. Polymorphisms in *Fads1* and *Fads2* have been shown to explain about 28% of the variation in 20:4n-6 in red blood cells in humans [@bb0160]. One implication of the present findings is that variations in the epigenetic regulation of *Fads2* may also contribute significantly variation in 20:4n-6 and 22:6n-3 concentrations.

A modest increase in the fat intake of adult non-pregnant female rats induced decreased liver PC 20:4n-6 and *Fads2* mRNA expression and increased the methylation of the same CpGs that were altered in the offspring of dams fed an HF diet. However, in contrast to the persistent effect of the maternal HF diet on the epigenetic regulation of *Fads2*, the changes induced in *Fads2* methylation and expression and in 20:4n-6 status in adults did not persist after a 'wash out' period of feeding AIN-93M. These findings suggest that there is epigenetic plasticity in the *Fads2* gene in adulthood and that fat intake can alter the DNA methylation of its promoter. However, unlike exposure to an HF diet during development that induced a persistent change on *Fads2* methylation and expression, there appears in adulthood to be a homeostatic mechanism that returns the level of methylation and transcription of the original state after the period of HF feeding ended. This suggests that although DNA methylation is regarded as a mechanism that induces stable changes in gene expression, methylation of specific CpGs in the *Fads2* promoter appears to be relatively dynamic. Szyf has proposed that an equilibrium between DNA methyltransferases and, as yet to be identified, demethylases is involved [@bb0165], although current experimental evidence is largely circumstantial. One implication of these findings is that short-term changes in the methylation of the *Fads2* promoter may contribute to the regulation of its expression by dietary fat [@bb0085].

The proportions of PUFA in cell membranes modify cell function by modulating the biophysical properties of the lipid bilayer and by determining the composition of substrate pools for the synthesis of lipid second messengers [@bb0170]. Thus, induction of long-term changes in PUFA synthesis may have important consequences for tissue function and potentially for disease risk, although the effect in humans may differ from that in rats because of differences between species in dietary PUFA intake, particularly of preformed 20:4n-6 and 22:6n-3. Female rats and humans maintain higher levels of 22:6n-3 in liver and/or plasma phospholipids and appear to synthesise more 22:6n-3 than males [@bb0170]. Although the precise biological function of this sex difference is not known, it has been suggested to be associated with the ability to increase 22:6n-3 status in pregnancy to meet the demands of the developing fetus and neonate [@bb0125; @bb0175]. Thus, variations in maternal fat intake during pregnancy and lactation acting via altered epigenetic regulation of *Fads2* transcription in the female offspring may, in turn, have an adverse effect on the capacity of the female offspring to synthesise long-chain PUFA during their pregnancy. If so, pregnant and lactating females who consume an HF diet, even a diet enriched in n-3 long-chain PUFA, may be less able to provide adequate amounts of these fatty acids to their offspring for optimal growth and development and so negatively influence their offspring\'s future health.

Appendix A. Supplementary data {#s0075}
==============================
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![Effect of feeding adult female rats a diet enriched in FO on the 20:4n-6 and 22:6n-3 in PC, *Fads1* and *Fads2* mRNA expression and methylation of specific CpG dinucleotides in the *Fads2* promoter in liver. Values are mean±S.D. for *n*=6 rats dietary group. Means without a common letter differ significantly (*P*\<.05), a\<b\<c. (A) and (B) are proportions of 20:4n-6 and 22:6n-3; (C) and (D) are *Fads1* and *Fads2* mRNA expression; (E--H) are methylation of specific CpG dinucleotides in the *Fads2* promoter. Degrees of freedom: T, type of maternal dietary fat, 1; S, sex, 1; A × S, 2; S × T, 1; A × T, 2; A × S × T, 2.](gr3){#f0015}
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Proportions of 20:4n-6 and 22:6n-3 in liver and plasma in adult offspring of rats fed diets with differing in fat contents during pregnancy and lactation

  Diet fat    Liver                   Plasma                                                                                                                                                       
  ----------- ----------------------- ---------------- ----------------- ----------------- ---------------- ----------------- ------------- ------------- ------------- ------------- ------------ ------------
              *% total fatty acids*                                                                                                                                                                
  Male                                                                                                                                                                                             
   LF         29.6±0.8^b^             27.9±2.3^b^      6.9±0.7^b^        6.8±0.8^b^        29.0±1.0^c^      27.4±3.s^c^       12.4±1.6^c^   13.3±2.1^c^   27.2±0.3^b^   26.1±0.3^b^   7.7±0.4^b^   6.8±0.3^b^
   AF         28.1±2.3^b^             26.8±2.7^b^      8.3±1.9^b^        7.0±1.3^b^        17.0±1.2^b^      20.6±2.0^b^       11.9±2.0^b^   9.3±2.5^b^    25.6±1.1^b^   23.2±1.1^b^   4.3±0.4^a^   3.9±1.3^a^
   HF         22.2±2.6^a^             20.0±2.1^a^      4.9±1.1^a^        5.2±0.7^a^        9.2±1.9^a^       11.5±2.5^a^       10.3±0.4^a^   6.7±0.7^a^    21.4±1.1^a^   18.5±3.1^a^   3.8±0.9^a^   2.7±08^a^
  Female                                                                                                                                                                                           
   LF         29.9±1.2^b^             26.3±1.0^b^      11.0±0.8^b^       11.1±0.4^b^       26.0±2.4^c^      23.0±0.6^c^       17.1±1.2^c^   20.6±0.9^c^   27.1±0.3^c^   25.8±0.9^c^   8.8±0.4^b^   7.2±0.2^b^
   AF         27.2±2.1^b^             26.1±1.4^b^      10.1±3.2^b^       12.0±1.2^b^       20.0±1.3^b^      18.7±3.2^b^       12.2±1.3^b^   14.9±1.7^b^   24.7±1.2^b^   23.2±2.1^b^   6.0±0.5^b^   5.5±0.6^b^
   HF         18.8±9.2^a^             20.2±2.9^a^      6.8±3.7^a^        8.3±0.6^a^        5.6±2.1^a^       9.0±1.7^a^        9.8±1.8^a^    8.4±0.6^a^    19.4±1.1^a^   18.1±1.6^a^   4.6±0.5^a^   3.8±0.7^a^
              *ANOVA \[P (F)\]*                                                                                                                                                                    
  A           *P*\<.0001 (69.0)       .002 (6.9)       \<.0001 (319.4)   \<.0001 (259.2)   \<.0001 (68.4)   \<.001 (126.0)                                                                         
  T           .02 (5.4)               --               --                --                \<.0001 (17.2)   --                                                                                     
  S           --                      \<.0001 (58.2)   \<.0001 (16.0)    --                \<.0001 (78.2)   \<.0001 (241.1)                                                                        
  A × S       --                      --               \<.0001 (8.7)     \<.0001 (13.4)    --               .001 (8.2)                                                                             
  S × T       --                      .02 (6.1)        --                \<.0001 (14.6)    --               --                                                                                     
  A × T       --                      --               .002 (7.1)        \<.0001 (9.4)     .14              --                                                                                     
  A × S × T   --                      --               .03 (3.7)         --                --               --                                                                                     

Values are mean±S.D., *n*=6. Means with superscripts without a common letter for each fatty acid within a sex differ, *P*\<.05; a\<b\<c. A, amount of maternal dietary fat; S, sex; T, type of maternal dietary fat. Degrees of freedom: A, 2; T, 1; S, 1; A × S, 2; S × T, 1; A × T, 2; A × S × T, 2.

###### 

Analysis of the relationship between the proportions of 20:4n-6 and 22:6n-3 in liver and plasma PC and *Fads2* mRNA expression and methylation in liver in adult offspring of rats fed diets with differing in fat contents during pregnancy and lactation

                    Liver                                              Plasma                                           *Fads2* mRNA                                                                                                                                                                                         
  ----------------- -------------------------------------------------- ------------------------------------------------ ----------------------------------------------- ------------------------------------------------ ------------------------------------------------- ------------------------------------------------- --------------------------------------------------
                    *r* (*r*^*2*^)                                                                                                                                                                                                                                                                                           
  Male (*n*=24)                                                                                                                                                                                                                                                                                                              
   *Fads2* mRNA     0.57[⁎⁎⁎](#tf0015){ref-type="table-fn"} (0.32)     0.61[⁎⁎⁎](#tf0015){ref-type="table-fn"} (0.37)   0.31[⁎](#tf0005){ref-type="table-fn"} (0.1)     0.54[⁎⁎⁎](#tf0015){ref-type="table-fn"} (0.29)   0.51[⁎⁎](#tf0010){ref-type="table-fn"} (0.26)     0.23[⁎](#tf0005){ref-type="table-fn"} (0.05)      
   CpG −623         −0.25                                              −0.31                                            −0.11                                           −0.16                                            −0.24                                             −0.12                                             −0.27[⁎](#tf0005){ref-type="table-fn"} (.07)
   CpG −394         −0.59[⁎⁎](#tf0010){ref-type="table-fn"} (0.35)     −0.57[⁎⁎](#tf0010){ref-type="table-fn"} (0.32)   −0.32[⁎](#tf0005){ref-type="table-fn"} (0.1)    −0.53[⁎⁎](#tf0010){ref-type="table-fn"} (0.28)   −0.57[⁎⁎](#tf0010){ref-type="table-fn"} (0.32)    −0.43[⁎](#tf0005){ref-type="table-fn"} (0.18)     −0.70[⁎⁎⁎⁎](#tf0020){ref-type="table-fn"} (0.49)
   CpG −84          −0.25                                              −0.11                                            −0.11                                           −0.27                                            −0.19                                             −0.08                                             −0.23[⁎](#tf0005){ref-type="table-fn"} (0.05)
   CpG −76          −0.1                                               −0.22                                            −0.08                                           −0.19                                            −0.23                                             −0.29                                             −0.15
  Female (*n*=24)                                                                                                                                                                                                                                                                                                            
   *Fads2* mRNA     0.42[⁎](#tf0005){ref-type="table-fn"} (0.18)       0.60[⁎⁎](#tf0010){ref-type="table-fn"} (0.36)    0.32[⁎](#tf0005){ref-type="table-fn"} (0.1)     0.43[⁎⁎](#tf0010){ref-type="table-fn"} (0.18)    0.49[⁎⁎](#tf0010){ref-type="table-fn"} (0.24)     0.55[⁎⁎⁎⁎](#tf0020){ref-type="table-fn"} (0.3)    
   CpG −623         −0.17                                              0.12                                             −0.15                                           −0.17                                            −0.23[⁎](#tf0005){ref-type="table-fn"}            −0.27                                             −0.34[⁎](#tf0005){ref-type="table-fn"} (0.12)
   CpG −394         −0.70[⁎⁎⁎⁎](#tf0020){ref-type="table-fn"} (0.49)   −0.54[⁎⁎](#tf0010){ref-type="table-fn"} (0.29)   −0.27[⁎](#tf0005){ref-type="table-fn"} (0.07)   −0.78[⁎⁎](#tf0010){ref-type="table-fn"} (0.61)   −0.71[⁎⁎⁎⁎](#tf0020){ref-type="table-fn"} (0.5)   −0.63[⁎⁎⁎⁎](#tf0020){ref-type="table-fn"} (0.4)   −0.71[⁎⁎⁎⁎](#tf0020){ref-type="table-fn"} (0.5)
   CpG −84          −0.16                                              0.25                                             −0.19                                           −0.23                                            −0.24                                             −0.16                                             −0.21[⁎](#tf0005){ref-type="table-fn"} (0.04)
   CpG −76          −0.20                                              −0.19                                            −0.412                                          −0.19                                            −0.14                                             −0.26                                             −0.01

*P*\<.05.

*P*\<.01.

*P*\<.001.

*P*\<.0001.

[^1]: These authors contributed equally to the work.
